TCL Archive Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock December 17, 2013
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive In Brief: Garb Raps “Hostility Of Executive Branch”; Hew Considers Allowing Grants For Industry April 25, 1980
TCL Archive In Brief: Responses To Control Grants Guidelines Pour Into NCI, Some From Grantsmen “Old Pros” November 23, 1974